Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lidija Šver is active.

Publication


Featured researches published by Lidija Šver.


Toxicon | 2003

Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom

Lidija Šver; S. Verstovsek; Svjetlana Terzić; Ivan Bašić

The possible tumor growth- and metastasis-inhibiting effects of bee venom in mice and in tumor cell cultures were studied. The tumor was a transplantable mammary carcinoma (MCa) of CBA mouse. Intravenous administration of bee venom to mice significantly reduced the number of metastases in the lung. However, subcutaneous administration of bee venom did not reduce the number of lung metastases, indicating that the antitumor effect of the venom could be highly dependent on the route of injection as well as close contact between the components of the venom and the tumor cells, as was shown by in vitro studies on MCa cells. We also observed variations in immunological parameter induced by bee venom. We proposed that bee venom has an indirect mechanism of tumor growth inhibition and promotion of tumor rejection that is based on stimulation of the local cellular immune responses in lymph nodes. Apoptosis, necrosis, and lysis of tumor cells are other possible mechanisms by which bee venom inhibits tumor growth.


Comparative Immunology Microbiology and Infectious Diseases | 1996

A royal jelly as a new potential immunomodulator in rats and mice

Lidija Šver; Zoran Tadić; Bela Njari; Ivica Valpotić; Ivan Bašić

In order to study a possible immunomodulatory effect of the royal jelly (RJ) secreted by mandibular and hypopharingeal glands of the worker honeybee (Apis mellifera Linné.) we have used a well established rodent model. The CBA mice were given s.c. 0.1 ml of RJ, 7 days before, or immediately after, the immunization with sheep red blood cells (SRBC). The Y59 rats received i.m. 0.4 ml or i.v. 0.025 ml of RJ once or twice at 7 day intervals. Serum levels of total proteins and immunoglobulins in the rats that received RJ once or twice within a 2-week-period were significantly lower (P < or = 0.05) as compared with the nontreated animals. In mice which were immunized with 4 x 10(8) of SRBC 7 days after the application of RJ the number of plaque forming splenocytes was significantly higher (P < or = 0.05) than that in the controls. Both the weight of inguinal lymph node and the number of peripheral blood lymphocytes were increased (P < or = 0.05) in RJ-treated mice 3 or 5 days after the immunization, respectively. Neutrophils were decreased (P < or = 0.05) in the mice that were killed 5 or 10 days after the RJ treatment. Overall these results indicate that RJ exhibited immunomodulatory properties by stimulating antibody production and immunocompetent cell proliferation in mice or depressing humoral immune functions in rats. Both phenomena, though species-related in this model, could probably be reversed by changing the dose or the route of RJ application.


Veterinary Immunology and Immunopathology | 1998

Summary of workshop findings for antibodies reacting with porcine T-cells and activation antigens: results from the Second International Swine CD Workshop

Mark D. Pescovitz; B.K Book; Bent Aasted; Javier Domínguez; A. Ezquerra; I. Trebichavsky; B. Novikov; Ivica Valpotić; Lidija Šver; Jens Nielsen; Scott Arn; David H. Sachs; Joan K. Lunney; P.C Boyd; John K. Walker; R. Lee; William C. Davis; I.R Barbosa; Federico A. Zuckermann; Armin Saalmüller

After initial evaluation of the 176 new and 19 control monoclonal antibodies (mAb) submitted to the Second International Swine CD Workshop, 57 were assigned to the T-cell/activation marker subgroup. These 57 mAb were further analyzed using flow cytometry on whole blood lymphocytes, splenocytes, Peyers patch lymphocytes, in vitro cell lines, broncho-alveolar lavage cells, Con A and PHA blasts, fetal cell populations, and by 2-color flow cytometry against mAb to porcine CD2, CD4, and CD8. Finally, the molecular weights of the target antigens were characterized when possible. As a result of these analyses, 23 mAb were distributed into 7 CD clusters. Newly confirmed mAb assignments included: two CD2; one CD4; two CD5; one wCD6; and one wCD25. Three new mAb were found that reacted with wCD8, one of which defined a new epitope, wCD8c. For the first time, mAb against porcine CD3 were identified, including 6 mAb that reacted with three different epitopes. Several new mAb reacted with antigens whose expression varied depending on the activation state of the test cell. These will require further characterization in order to assign a CD number.


Veterinary and Comparative Oncology | 2003

Influence of honey bee products on transplantable murine tumours

Knezević A; Lidija Šver; Terzić S; Hackenberger Bk; Ivan Bašić

The effect of propolis [it is a water-soluble derivative (WSDP)] and related polyphenolic compounds of propolis (caffeic acid, caffeic acid phenethyl ester and quercetin), honey, royal jelly and bee venom on tumour growth, metastasizing ability and induction of apoptosis and necrosis in murine tumour models (mammary carcinoma and colon carcinoma) was investigated. WSDP and related polyphenolic compounds showed significant anti-metastatic effect (P < 0.01 and P < 0.001) given either before or after tumour-cell inoculation. Oral or systemic application of WSDP or caffeic acid significantly reduced subcutaneous tumour growth and prolonged the survival of mice. Honey also exerted pronounced anti-metastatic effect (P < 0.05) when applied before tumour-cell inoculation (peroral 2 g kg(-1) for mice or 1 g kg(-1) for rats, once a day for 10 consecutive days). Royal jelly did not affect metastasis formation when given intraperitoneally or subcutaneously. However, intravenous administration of royal jelly before tumour-cell inoculation significantly (P < 0.05) inhibited metastasis formation. When mice were given 10(5) tumour cells intravenously immediately after bee venom injection, the number of tumour nodules in the lung was significantly lower (P < 0.001) than in untreated mice or mice treated with bee venom subcutaneously. Local presence of bee venom in the tissue caused significant delay in subcutaneous tumour formation. These findings clearly demonstrate that anti-tumour and anti-metastatic effects of bee venom are highly dependent on the route of injection and on close contact between components of the bee venom and tumour cells. These data show that honey bee products given orally or systemically may have an important role in the control of tumour growth and tumour metastasizing ability.


Nutrition and Cancer | 2003

Inhibitory Effect of Water-Soluble Derivative of Propolis and Its Polyphenolic Compounds on Tumor Growth and Metastasizing Ability: A Possible Mode of Antitumor Action

Lidija Šver; Svjetlana Terzić; Zoran Tadić; Ivan Bašić

Polyphenolic compounds are widely distributed in the plant kingdom and display a variety of biological activities, including chemoprevention and tumor growth inhibition. Propolis is made up of a variety of polyphenolic compounds. We compared how the routes of administration of polyphenolic compounds deriving from propolis and of propolis itself affect the growth and metastatic potential of a transplantable mammary carcinoma (MCa) of the CBA mouse. The influence of tested compounds on local tumor growth was also studied. Metastases in the lung were generated by 2 × 105 tumor cells injected intravenously (IV). A water-soluble derivative of propolis (WSDP) and polyphenolic compounds (caffeic acid, CA, and CA phenethyl ester, CAPE) were given to mice per os (PO) or intraperitoneally (IP) before or after tumor cell inoculation. Tested compounds significantly decreased the number of lung colonies. When mice were inoculated with 105 MCa cells in the exact site of subcutaneous injection of different doses of WSDP, CA, or CAPE, tumor growth was inhibited, and survival of treated mice was prolonged. Antitumor activity, according to the results obtained, is mostly related to the immunomodulatory properties of the compounds and their capacity to induce apoptosis and necrosis. In conclusion, results presented here indicate that WSDP, CA, and CAPE could be potential useful tools in the control of tumor growth in experimental tumor models when administrated PO; because PO administration is the easiest way of introducing a compound used for prevention and/or cure of any disease, it is likely that this article has reached the goal of the investigation.


Veterinary Research Communications | 2005

Peroral application of water-soluble derivative of propolis (WSDP) and its related polyphenolic compounds and their influence on immunological and antitumour activity.

Lidija Šver; Svjetlana Terzić; Ivan Bašić

Polyphenolic compounds are widely distributed in the plant kingdom and display a variety of biological activities, including chemoprevention and growth inhibition of tumours. Propolis contains a conglomerate of polyphenolic compounds. We investigated the effect of propolis and polyphenolic compounds, components of propolis, on the growth and metastatic potential of a transplantable mammary carcinoma (MCa) of the mouse. Metastases in the lung were generated by 2 x 10 tumour cells injected intravenously (i.v.). A water-soluble derivative of propolis (WSDP) and the polyphenolic compounds (caffeic acid (CA) and caffeic acid phenethyl ester (CAPE)) were given to mice perorally before or after tumour cell inoculation. WSDP, CA and CAPE reduced the number of metastases in the lung. This implies that the antitumour activities of the compounds used in these studies are mostly related to the immunomodulatory properties of the compounds, their cytotoxicity to tumour cells, and their ability to induce apoptosis and/or necrosis.


Veterinary Immunology and Immunopathology | 2001

Summary of the first round analyses of the Third International Workshop on Swine Leukocyte Differentiation Antigens

Karin Haverson; Armin Saalmüller; Z. Chen; Christene A. Huang; A. Simon; J. Seebach; W.J.A. Boersma; R.J Zwart; Theodoor Niewold; Eileen L. Thacker; D. Llanes; J.M.P.de la Lastra; H. Engelhardt; A. Ezquerra; Fernando Alonso; Javier Domínguez; J.A. Ledbetter; L.S. Grosmaire; R. Lee; Jens Nielsen; Henri Salmon; Ivica Valpotić; Lidija Šver; Gordana Lacković; Artur Summerfield; K.V. Khanna

The reactivity of 155 monoclonal antibodies submitted to the Third International Workshop on Swine Leukocyte Differentiation Antigens, together with 41 internal standards, was analysed by flow cytometry on 29 different pig cell targets as well as two human cell targets as a means of establishing suitable panels of monoclonal antibodies for more detailed clustering analyses by the various subsections of the workshop. Results were collected either without further gating, with gating based on FS/SS characteristics or with gating based on the co-expression of a reference antibody in two-colour flow cytometry. The CD or SWC reactivity of the internal standards had been established in previous workshops. Data sets were subsequently analysed by statistical clustering using the Leucocyte Typing Database IV software. The resulting 18 cluster groups were allocated to the appropriate second round sections of the workshop, after reviewing the overall cellular reactivity of each cluster as well as the specificity of known standards which clustered in a group.


Veterinary Research Communications | 2003

Comparison of Antibody Values in Sera of Pigs Vaccinated with a Subunit or an Attenuated Vaccine against Classical Swine Fever

Svjetlana Terzić; Lorena Jemeršić; Mirko Lojkić; Josip Madić; Joža Grom; Ivan Toplak; Lidija Šver; Ivica Valpotić

Ten pigs, aged 85 days, were vaccinated with a subunit vaccine containing 32 μg of classical swine fever virus glycoprotein E2 (gp E2) (group 1), and a further 10 pigs were vaccinated with a C strain vaccine (104±0.15 TCID50/ml), produced by amplification in minipig kidney (MPK) cell culture (group 2). Nine non-vaccinated pigs served as a control group (group 3). Serum samples were collected before (day 0) and at 4, 10, 21 and 28 days after vaccination and were analysed by two commercially available enzyme immunoassays and by a neutralizing peroxidase-linked assay (NPLA). At the same times, peripheral blood was taken for determining the total leukocyte count and the body temperature was taken daily. Antibodies were not detected in serum samples collected before vaccination (day 0), and no side-effects that could be connected with vaccination were observed during the trial. Ten days after vaccination 6/10 pigs vaccinated with the subunit vaccine were seropositive. On days 21 and 28, the ratios of serologically positive to vaccinated pigs were 9/10 and 10/10, respectively. Four of the ten pigs that were vaccinated with the C strain vaccine were positive on day 21 and 9/10 on day 28. However, the results of the NPLA showed that only 4/10 pigs had an antibody titre >1:32 at the end of the trial in both the vaccinated groups, even though the subunit vaccine initiated an earlier and higher level of neutralizing antibodies than the vaccine produced from the C strain. Challenge was performed 28 days after vaccination on four randomly selected pigs from both vaccinated groups. The pigs survived the challenge without showing any clinical signs of classical swine fever (CSF), while two nonvaccinated control pigs died on the 10th and 12th days after infection.


Food and Agricultural Immunology | 2005

Polyphenolic compounds from propolis modulate immune responses and increase host resistance to tumour cells

Svjetlana Terzić; Lidija Šver; Ivan Bašić

Abstract Propolis contains a variety of polyphenolic compounds. We investigated the effect of a water-soluble derivatives of propolis (WSDP) and polyphenolic compounds, components of propolis, on growth of Ehrlich ascites tumour (EAT) in mice. Tumour in peritoneal cavity was produced by 2×106 EAT cells. WSDP and polyphenolic compounds (caffeic acid-CA, caffeic acid phenethyl ester-CAPE and quercetin-QU) were given to mice perorally (po). It was found that the volume of ascitic fluid induced by EAT cells and total number of cells present in the peritoneal cavity was markedly reduced in EAT-bearing mice treated with test components and the survival time of treated mice was prolonged. Inhibition of EAT growth was due to their effect on the immune system of mice. When innate and acquired immune responses were evaluated, a dose-related increase of cytotoxic T-cell, NK and B cells activity was observed in test components-treated mice. Furthermore, exposure of animals to test components increased functional activity of macrophages to produce factors regulating the function of B-, T-, and NK- cells respectively. In conclusion, these findings imply that the antitumour activity of WSDP and polyphenolic compounds of propolis enhanced host resistance in the EAT tumour model, increasing the activities of macrophages, cytotoxic T cells, B cells and NK cells.


Arhiv Za Higijenu Rada I Toksikologiju | 2014

First evidence of the P-glycoprotein gene expression and multixenobiotic resistance modulation in earthworm

Ivana Bošnjak; Ana Bielen; Sanja Babić; Lidija Šver; Natalija Topić Popović; Ivančica Strunjak-Perović; Rozelindra Čož-Rakovac; Roberta Sauerborn Klobučar

Summary Multixenobiotic resistance (MXR) is an important mechanism of cellular efflux mediated by ATP binding cassette (ABC) transporters that bind and actively remove toxic substrates from the cell. This study was the first to identify ABC transporter P-glycoprotein (P-gp/ABCB1) as a representative of the MXR phenotype in earthworm (Eisenia fetida). The identified partial cDNA sequence of ABCB1 overlapped with ABCB1 homologues of other organisms from 58.5 % to 72.5 %. We also studied the effect of five modulators (verapamil, cyclosporine A, MK571, probenecid, and orthovanadate) on the earthworm’s MXR activity by measuring the accumulation of model substrates rhodamine B and rhodamine 123 in whole body tissue of the adult earthworm. MK571, orthovanadate, and verapamil significantly inhibited MXR activity, and rhodamine 123 turned out to better reflect MXR activity in that species than rhodamine B. Our results show that E. fetida can serve well as a test organism for environmental pollutants that inhibit MXR activity. Sažetak Mehanizam multiksenobiotičke otpornosti (MXR) prisutan je u mnogim organizmima kao važan stanični detoksikacijski mehanizam. Posredovan je aktivnošću ABC prijenosnika koji vežu i aktivno izbacuju različite toksične tvari iz stanice. U ovom radu dani su podaci o molekularnoj identifikaciji ABC prijenosnika (eksportera) - P-glikoproteina (P-gp/Abcb1), kao jednog od predstavnika MXR fenotipa, u gujavici Eisenia fetida. Određen je djelomični slijed identificiranoga gena Abcb1, njegov predviđeni aminokiselinski slijed uspoređen je s ABCB1 homolozima iz drugih organizama i utvrđena je identičnost od 58,5 do72,5 %. Uz to, istraživali smo učinak pet modulatora (verapamil, ciklosporin, MK571, probenecid, ortovanadat) na aktivnost MXR mehanizma tih gujavica. Kako bismo potvrdili modulirajuće djelovanje istraživanih modelnih inhibitora na MXR mehanizam u E. fetida, mjerili smo akumulaciju modelnih supstrata rodamina B (RB) i rodamina 123 (R123) u tijelu spolno zrelih jedinki gujavica testom izlaganja na filtar papiru. Rezultati su pokazali da svi istraživani modulatori značajno inhibiraju MXR transportnu aktivnost. Naši podaci prvi upućuju na prisutnost P-gp/Abcb1 srodnih gena u gujavici E. fetida. Osim toga, ukazali smo na veliku važnost MXR-a kao specifičnog detoksikacijskog mehanizma koji omogućuje preživljavanje gujavica u onečišćenom okolišu.

Collaboration


Dive into the Lidija Šver's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Armin Saalmüller

University of Veterinary Medicine Vienna

View shared research outputs
Top Co-Authors

Avatar

Jens Nielsen

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge